Business
Cytophage Announces Closing of First Tranche of Non-Brokered Private Placement
(TheNewswire) WINNIPEG, November 12, 2025 — TheNewswire – Cytopha...
About this update from Cytophage Technologies Ltd.
[{"type":"text","content":" Cytophage Announces Closing of First Tranche of Non-Brokered Private Placement \n\n\n (TheNewswire)\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n WINNIPEG, November 12,\n2025\n \n\n —\n \n\n TheNewswire –\n \n\n Cytophage Technologies Ltd. (“\n \n\n Cytophage\n \n\n ” or the\n“\n \n\n Company\n \n\n ”) (TSXV: CYTO, FSE: 70G) today reported that it has closed\nthe first-tranche of its previously announced non-brokered private\nplacement (the “\n \n\n Offering\n \n\n ”). The full details of the Offering\nwere announced in\n \n\n\n\n a press release dated\nOctober 17, 2025\n \n\n\n\n .  In connection\nwith the first--tranche closing, the Company raised $1.002M of gross\nproceeds by issuing a total of 5,010,000 Units to\n \n\n investors\n \n\n .\n \n\n\n\n The Company plans to close a secondary tranche of the\nOffering on or about November 17, 2025. As stated in its earlier press\nrelease, the Company may also increase the size of the Offering by\nissuing up to an additional 3,000,000 Units for additional gross\nproceeds of up to $600,000 to accommodate additional demand from\ninvestors.\n \n\n\n\n Each Unit consists of one (1) common share of the\nCompany (a “Share”) and one half (1/2) of a common share purchase\nwarrant (a “Warrant”). Each whole Warrant entitles the holder\nthereof to purchase one (1) additional Share ( a “Warrant Share”)\nat a price of C$0.40 per Warrant Share, for a period of 24 months from\nthe date of issuance. Cytophage may accelerate the expiry of the\nWarrants if the volume weighted average trading price of its Common\nShares on the TSX Venture Exchange equals or exceed $0.60 for a period\nof 10 consecutive trading days (the “Acceleration Right”). In the\nevent that Cytophage exercises the Acceleration Right it will do so by\nproviding notice to all holders of Warrants.\n \n\n\n\n In connection with the first-tranche closing, the\nCompany has also agreed, subject to receiving Exchange approval, to\npay finder’s fees of $\n \n\n 34,440\n \n\n in cash and to 172,200 broker warrants, on the same terms as\nthe Warrants forming part of the Offering, to qualified non related\nparties. In accordance with the rules and policies of the Exchange and\napplicable Canadian secur...